Contact this trialFirst, we need to learn more about you.
Anti-metabolites
MK-3475 + Gemcitabine for Lung Cancer
Recruiting1 awardPhase 1 & 2
Portland, Oregon
This trial is for patients with advanced NSCLC who have been treated before. It will test the safety of adding MK-3475 (an investigational drug) to standard treatment with gemcitabine, as well as trying to identify the best dose of MK-3475 to give in combination with gemcitabine.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.